Targinine

N/A

Report date: 2024/07/05 20:00:49
NME

Base Information

Drug NameTarginine
Drug Alias Name他吉宁NMAL-NMMA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric-oxide synthase, brain inhibitorsNitric-oxide synthase, endothelial inhibitorsNitric oxide synthase, inducible inhibitors
TargetsNitric-oxide synthase, brainNitric-oxide synthase, endothelialNitric oxide synthase, inducible
Therapy Area/IndicationsGastrointestinal motility disordersHypercapniaHypoxia +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Wisconsin-Madison
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)Radboud University Medical CenterArginox Pharmaceuticals Inc +[9] 
Active IndicationsMetabolic SyndromeCerebral Arterial Diseases
Inactive IndicationsGastrointestinal motility disordersHypercapniaHypoxia +[14] 

Other Information

ATC CodeN/A
Related LinksWikipedia